In the last 12 months, nearly 10,000 children across England have had an objective assessment for Attention Deficit Hyperactivity Disorder (ADHD), using AHSN-supported technology.
ADHD is a neurodevelopmental disorder and affects around 5% of school-aged children worldwide. Symptoms include inattentiveness, hyperactivity and impulsiveness. If undiagnosed and/or untreated ADHD can have a significant impact on personal development, academic outcomes, and social interaction. Mental health charity Mind also indicate that those with ADHD are more likely to experience a mental health problem.
Focus ADHD, the AHSN Network national programme, uses technology created by international health technology company Qbtech Ltd. The QbTest is a computer-based test that simultaneously measures the key symptoms of ADHD, and when added to the diagnostic process can reduce time to decision by approximately five months (153 days).
The results are instantly analysed and presented in a report that compares a patients’ results against a normative dataset, based on age and gender.
Following an initial pause in testing due to coronavirus, in the last six months an additional 2,146 children have received an objective assessment for ADHD, as a direct result of a new AHSN Network national programme, which started in April 2020.
Nicole McGlennon, Managing Director, East Midlands AHSN said: “The East Midlands AHSN delivered a 12-month, real-world demonstrator project, where the test was deployed and evaluated in three East Midlands trusts. Our findings showed that using the test to supplement current clinical assessment processes not only reduced diagnosis time, but that 94% of clinicians and 85% of patients found the tool helpful.
“Focus ADHD can help release clinicians’ capacity, reduce waiting lists, improve treatment and allow more time to concentrate on complex cases.”
Consultant Paediatrician at United Lincolnshire Hospitals said: “I can honestly say that this innovation has revolutionised my clinical practice. The feedback from clinicians, parents and schools so far has all been extremely positive. We are already planning how we can extend into other areas.”
Collectively evidence shows how the programme can improve the experience for children and their families as well as save time and money for the health and care system.
Following the results demonstrated by the East Midlands AHSN, the Focus ADHD programme was selected as an AHSN Network national adoption and spread programme for roll out in April 2020. As a result, at least one NHS trust in 14 of the Network’s 15 regions now offers this intervention.
 NICE. (2008). Attention deficit hyperactivity disorder: Diagnosis and management of ADHD in children, young people and adults. Clinical Guideline 72. London: National Institute for Health and Clinical Excellence.
 October 2020-end of March 2021